Ann: FDA Provides Clear Feedback for ODD Approval, page-274

TH before open tomorrow open?

Company will have data now in their possession
Editorial being written up, News Embargoed until Open on Wednesday , Rare Disease Day

Media Presentation will be garnishing 3 coats of Gloss ,
ASX Announcement Crafted by Wordsmiths , ( Checked for spelling mistakes a Typo's)

Remember the more positive the data the greater the scrutiny will be..
PAA are about to poke their heads up in a field of some very tall poppies ,,, They're not called Fortune 500 Companies for nothing .....

The most exciting and Pivotal Moment in PAA's History.

This Phase I/II Data also represents the Tolerability and Safety Data that is required to move forward not only with MND but any other Target that PAA choose,

MPL is no Same Same Drug , this looks to be a whole new class of medicine utilising the mTOR Pathway which until now has been incredibly difficult to unlock with any certainty...

With the stock so tightly held we should see a significant Spread on the Buy Side,, don't be shocked if you see multiples if not 10's of cent gains..
At one stage on Friday the spread was 960,000 shares to 68 cents , we have been pulling 3m/5m day volume , during the covid run we hit a day of 27m volume.... I don't have a crystal ball , Usually I would have derisked my position and entered again on the other side of Positive Results.. BUT if this goes the way I'm seeing the delivery of positive results to market unfold (and we can all see how PAA value Market Messaging) we should be in for a very exciting and financially rewarding couple of days... The climb is going to be swift and steep

Just bought enough fresh ground coffee that could stimulate a Race Horse ,,,,NZT